Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • For Subscribers
    • For Advertisers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • For Subscribers
    • For Advertisers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Index by author

September 01, 1987; Volume 15,Issue 5
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Alexander, D P

    1. You have access
      Effect of cyclosporine on hepatic oxidative and conjugative metabolism in rats.
      R E Galinsky, D P Alexander and M R Franklin
      Drug Metabolism and Disposition September 1987, 15 (5) 731-733;

B

  1. Babish, J G

    1. You have access
      The development of hepatic drug-metabolizing enzyme activity in the neonatal calf and its effect on drug disposition.
      S E Shoaf, W S Schwark, C L Guard and J G Babish
      Drug Metabolism and Disposition September 1987, 15 (5) 676-681;
  2. Bailie, M B

    1. You have access
      Pharmacokinetics of acetaminophen, vancomycin, and antipyrine in the Hanford miniature swine.
      M B Bailie, D A Federowicz, K Dolce, C Kahn, B A Mico and M S Landi
      Drug Metabolism and Disposition September 1987, 15 (5) 729-730;
  3. Balis, F M

    1. You have access
      The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeys.
      J A Kelley, C L Litterst, J S Roth, D T Vistica, D G Poplack, D A Cooney, M Nadkarni, F M Balis, S Broder and D G Johns
      Drug Metabolism and Disposition September 1987, 15 (5) 595-601;
  4. Brady, J F

    1. You have access
      Mechanism-based inhibition of cytochrome P-450 by heterocyclic analogues of phencyclidine.
      J F Brady, J Dokko, E W Di Stefano and A K Cho
      Drug Metabolism and Disposition September 1987, 15 (5) 648-652;
  5. Broder, S

    1. You have access
      The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeys.
      J A Kelley, C L Litterst, J S Roth, D T Vistica, D G Poplack, D A Cooney, M Nadkarni, F M Balis, S Broder and D G Johns
      Drug Metabolism and Disposition September 1987, 15 (5) 595-601;

C

  1. Caldwell, J

    1. You have access
      Criteria for the acceptability of experimental evidence for the enantiomeric composition of xenobiotics and their metabolites.
      J Caldwell and B Testa
      Drug Metabolism and Disposition September 1987, 15 (5) 587-588;
  2. Cary, P D

    1. You have access
      The metabolism of 7-ethylbenz[a]anthracene by rat liver microsomal preparations.
      S McKay, P B Farmer, P D Cary and P L Grover
      Drug Metabolism and Disposition September 1987, 15 (5) 682-694;
  3. Cederbaum, A I

    1. You have access
      Oxidation of the alcohol dehydrogenase inhibitor pyrazole to 4-hydroxypyrazole by microsomes. Effect of cytochrome P-450 inducing agents.
      D E Feierman and A I Cederbaum
      Drug Metabolism and Disposition September 1987, 15 (5) 634-639;
  4. Chen, L J

    1. You have access
      Influence of gonadal hormones upon rat hepatic acetaminophen sulfotransferases.
      R F Kane and L J Chen
      Drug Metabolism and Disposition September 1987, 15 (5) 725-728;
  5. Cho, A K

    1. You have access
      Mechanism-based inhibition of cytochrome P-450 by heterocyclic analogues of phencyclidine.
      J F Brady, J Dokko, E W Di Stefano and A K Cho
      Drug Metabolism and Disposition September 1987, 15 (5) 648-652;
  6. Cho, D K

    1. You have access
      Ketorolac tromethamine absorption, distribution, metabolism, excretion, and pharmacokinetics in animals and humans.
      E J Mroszczak, F W Lee, D Combs, F H Sarnquist, B L Huang, A T Wu, L G Tokes, M L Maddox and D K Cho
      Drug Metabolism and Disposition September 1987, 15 (5) 618-626;
  7. Combs, D

    1. You have access
      Ketorolac tromethamine absorption, distribution, metabolism, excretion, and pharmacokinetics in animals and humans.
      E J Mroszczak, F W Lee, D Combs, F H Sarnquist, B L Huang, A T Wu, L G Tokes, M L Maddox and D K Cho
      Drug Metabolism and Disposition September 1987, 15 (5) 618-626;
  8. Cooney, D A

    1. You have access
      The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeys.
      J A Kelley, C L Litterst, J S Roth, D T Vistica, D G Poplack, D A Cooney, M Nadkarni, F M Balis, S Broder and D G Johns
      Drug Metabolism and Disposition September 1987, 15 (5) 595-601;

D

  1. Dekant, W

    1. You have access
      Bioactivation of tetrachloroethylene. Role of glutathione S-transferase-catalyzed conjugation versus cytochrome P-450-dependent phospholipid alkylation.
      W Dekant, G Martens, S Vamvakas, M Metzler and D Henschler
      Drug Metabolism and Disposition September 1987, 15 (5) 702-709;
  2. Di Stefano, E W

    1. You have access
      Mechanism-based inhibition of cytochrome P-450 by heterocyclic analogues of phencyclidine.
      J F Brady, J Dokko, E W Di Stefano and A K Cho
      Drug Metabolism and Disposition September 1987, 15 (5) 648-652;
  3. Dokko, J

    1. You have access
      Mechanism-based inhibition of cytochrome P-450 by heterocyclic analogues of phencyclidine.
      J F Brady, J Dokko, E W Di Stefano and A K Cho
      Drug Metabolism and Disposition September 1987, 15 (5) 648-652;
  4. Dolce, K

    1. You have access
      Pharmacokinetics of acetaminophen, vancomycin, and antipyrine in the Hanford miniature swine.
      M B Bailie, D A Federowicz, K Dolce, C Kahn, B A Mico and M S Landi
      Drug Metabolism and Disposition September 1987, 15 (5) 729-730;

F

  1. Farmer, P B

    1. You have access
      The metabolism of 7-ethylbenz[a]anthracene by rat liver microsomal preparations.
      S McKay, P B Farmer, P D Cary and P L Grover
      Drug Metabolism and Disposition September 1987, 15 (5) 682-694;
  2. Federowicz, D A

    1. You have access
      Pharmacokinetics of acetaminophen, vancomycin, and antipyrine in the Hanford miniature swine.
      M B Bailie, D A Federowicz, K Dolce, C Kahn, B A Mico and M S Landi
      Drug Metabolism and Disposition September 1987, 15 (5) 729-730;
  3. Feierman, D E

    1. You have access
      Oxidation of the alcohol dehydrogenase inhibitor pyrazole to 4-hydroxypyrazole by microsomes. Effect of cytochrome P-450 inducing agents.
      D E Feierman and A I Cederbaum
      Drug Metabolism and Disposition September 1987, 15 (5) 634-639;
  4. Feil, V J

    1. You have access
      The disposition of N-(4,6-dimethyl-2-pyrimidinyl)benzene[U-14C]sulfonamide in the rat.
      G D Paulson and V J Feil
      Drug Metabolism and Disposition September 1987, 15 (5) 671-675;
  5. Franklin, M R

    1. You have access
      Effect of cyclosporine on hepatic oxidative and conjugative metabolism in rats.
      R E Galinsky, D P Alexander and M R Franklin
      Drug Metabolism and Disposition September 1987, 15 (5) 731-733;
  6. Fullerton, F R

    1. You have access
      Influence of a purified diet and route of administration on the metabolism and disposition of estradiol in B6C3F1 mice.
      F R Fullerton, D L Greenman and J F Young
      Drug Metabolism and Disposition September 1987, 15 (5) 602-607;

G

  1. Galinsky, R E

    1. You have access
      Effect of cyclosporine on hepatic oxidative and conjugative metabolism in rats.
      R E Galinsky, D P Alexander and M R Franklin
      Drug Metabolism and Disposition September 1987, 15 (5) 731-733;
  2. Goodwin, R M

    1. You have access
      Disposition of the monoclonal antibody-vinca alkaloid conjugate, KS1/4-DAVLB (LY256787), in Fischer 344 rats and rhesus monkeys.
      M E Spearman, R M Goodwin and D Kau
      Drug Metabolism and Disposition September 1987, 15 (5) 640-647;
  3. Gordon, W P

    1. You have access
      The metabolism of the abortifacient terpene, (R)-(+)-pulegone, to a proximate toxin, menthofuran.
      W P Gordon, A C Huitric, C L Seth, R H McClanahan and S D Nelson
      Drug Metabolism and Disposition September 1987, 15 (5) 589-594;
  4. Greenman, D L

    1. You have access
      Influence of a purified diet and route of administration on the metabolism and disposition of estradiol in B6C3F1 mice.
      F R Fullerton, D L Greenman and J F Young
      Drug Metabolism and Disposition September 1987, 15 (5) 602-607;
  5. Grover, P L

    1. You have access
      The metabolism of 7-ethylbenz[a]anthracene by rat liver microsomal preparations.
      S McKay, P B Farmer, P D Cary and P L Grover
      Drug Metabolism and Disposition September 1987, 15 (5) 682-694;
  6. Guard, C L

    1. You have access
      The development of hepatic drug-metabolizing enzyme activity in the neonatal calf and its effect on drug disposition.
      S E Shoaf, W S Schwark, C L Guard and J G Babish
      Drug Metabolism and Disposition September 1987, 15 (5) 676-681;

H

  1. Hartman, N R

    1. You have access
      The in vitro activity, radioimmunoassay cross-reactivity, and molecular weight of thirteen rabbit cyclosporine metabolites.
      N R Hartman and I Jardine
      Drug Metabolism and Disposition September 1987, 15 (5) 661-664;
  2. Henschler, D

    1. You have access
      Bioactivation of tetrachloroethylene. Role of glutathione S-transferase-catalyzed conjugation versus cytochrome P-450-dependent phospholipid alkylation.
      W Dekant, G Martens, S Vamvakas, M Metzler and D Henschler
      Drug Metabolism and Disposition September 1987, 15 (5) 702-709;
  3. Hoffmann, J S

    1. You have access
      Direct detection of new flucytosine metabolites in human biofluids by 19F nuclear magnetic resonance.
      J P Vialaneix, M C Malet-Martino, J S Hoffmann, J Pris and R Martino
      Drug Metabolism and Disposition September 1987, 15 (5) 718-724;
  4. Houston, J B

    1. You have access
      Glucuronidation in vitro and in vivo. Comparison of intestinal and hepatic conjugation of morphine, naloxone, and buprenorphine.
      M Mistry and J B Houston
      Drug Metabolism and Disposition September 1987, 15 (5) 710-717;
  5. Huang, B L

    1. You have access
      Ketorolac tromethamine absorption, distribution, metabolism, excretion, and pharmacokinetics in animals and humans.
      E J Mroszczak, F W Lee, D Combs, F H Sarnquist, B L Huang, A T Wu, L G Tokes, M L Maddox and D K Cho
      Drug Metabolism and Disposition September 1987, 15 (5) 618-626;
  6. Huitric, A C

    1. You have access
      The metabolism of the abortifacient terpene, (R)-(+)-pulegone, to a proximate toxin, menthofuran.
      W P Gordon, A C Huitric, C L Seth, R H McClanahan and S D Nelson
      Drug Metabolism and Disposition September 1987, 15 (5) 589-594;

J

  1. James, M O

    1. You have access
      In vivo and in vitro renal metabolism and excretion of benzoic acid by a marine teleost, the southern flounder.
      M O James and J B Pritchard
      Drug Metabolism and Disposition September 1987, 15 (5) 665-670;
  2. Jardine, I

    1. You have access
      The in vitro activity, radioimmunoassay cross-reactivity, and molecular weight of thirteen rabbit cyclosporine metabolites.
      N R Hartman and I Jardine
      Drug Metabolism and Disposition September 1987, 15 (5) 661-664;
  3. Johns, D G

    1. You have access
      The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeys.
      J A Kelley, C L Litterst, J S Roth, D T Vistica, D G Poplack, D A Cooney, M Nadkarni, F M Balis, S Broder and D G Johns
      Drug Metabolism and Disposition September 1987, 15 (5) 595-601;
  4. Jones, A D

    1. You have access
      Distribution of trans-4-hydroxy-2-hexenal and tandem mass spectrometric detection of its urinary mercapturic acid in the rat.
      C K Winter, H J Segall and A D Jones
      Drug Metabolism and Disposition September 1987, 15 (5) 608-612;

K

  1. Kahn, C

    1. You have access
      Pharmacokinetics of acetaminophen, vancomycin, and antipyrine in the Hanford miniature swine.
      M B Bailie, D A Federowicz, K Dolce, C Kahn, B A Mico and M S Landi
      Drug Metabolism and Disposition September 1987, 15 (5) 729-730;
  2. Kane, R F

    1. You have access
      Influence of gonadal hormones upon rat hepatic acetaminophen sulfotransferases.
      R F Kane and L J Chen
      Drug Metabolism and Disposition September 1987, 15 (5) 725-728;
  3. Kau, D

    1. You have access
      Disposition of the monoclonal antibody-vinca alkaloid conjugate, KS1/4-DAVLB (LY256787), in Fischer 344 rats and rhesus monkeys.
      M E Spearman, R M Goodwin and D Kau
      Drug Metabolism and Disposition September 1987, 15 (5) 640-647;
  4. Kelley, J A

    1. You have access
      The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeys.
      J A Kelley, C L Litterst, J S Roth, D T Vistica, D G Poplack, D A Cooney, M Nadkarni, F M Balis, S Broder and D G Johns
      Drug Metabolism and Disposition September 1987, 15 (5) 595-601;
  5. Khalique, A

    1. You have access
      Pharmacokinetics and pharmacodynamics of physostigmine in the rat after intravenous administration.
      S M Somani and A Khalique
      Drug Metabolism and Disposition September 1987, 15 (5) 627-633;

L

  1. Landi, M S

    1. You have access
      Pharmacokinetics of acetaminophen, vancomycin, and antipyrine in the Hanford miniature swine.
      M B Bailie, D A Federowicz, K Dolce, C Kahn, B A Mico and M S Landi
      Drug Metabolism and Disposition September 1987, 15 (5) 729-730;
  2. Lee, F W

    1. You have access
      Ketorolac tromethamine absorption, distribution, metabolism, excretion, and pharmacokinetics in animals and humans.
      E J Mroszczak, F W Lee, D Combs, F H Sarnquist, B L Huang, A T Wu, L G Tokes, M L Maddox and D K Cho
      Drug Metabolism and Disposition September 1987, 15 (5) 618-626;
  3. Litterst, C L

    1. You have access
      The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeys.
      J A Kelley, C L Litterst, J S Roth, D T Vistica, D G Poplack, D A Cooney, M Nadkarni, F M Balis, S Broder and D G Johns
      Drug Metabolism and Disposition September 1987, 15 (5) 595-601;

M

  1. Maddox, M L

    1. You have access
      Ketorolac tromethamine absorption, distribution, metabolism, excretion, and pharmacokinetics in animals and humans.
      E J Mroszczak, F W Lee, D Combs, F H Sarnquist, B L Huang, A T Wu, L G Tokes, M L Maddox and D K Cho
      Drug Metabolism and Disposition September 1987, 15 (5) 618-626;
  2. Malet-Martino, M C

    1. You have access
      Direct detection of new flucytosine metabolites in human biofluids by 19F nuclear magnetic resonance.
      J P Vialaneix, M C Malet-Martino, J S Hoffmann, J Pris and R Martino
      Drug Metabolism and Disposition September 1987, 15 (5) 718-724;
  3. Martens, G

    1. You have access
      Bioactivation of tetrachloroethylene. Role of glutathione S-transferase-catalyzed conjugation versus cytochrome P-450-dependent phospholipid alkylation.
      W Dekant, G Martens, S Vamvakas, M Metzler and D Henschler
      Drug Metabolism and Disposition September 1987, 15 (5) 702-709;
  4. Martino, R

    1. You have access
      Direct detection of new flucytosine metabolites in human biofluids by 19F nuclear magnetic resonance.
      J P Vialaneix, M C Malet-Martino, J S Hoffmann, J Pris and R Martino
      Drug Metabolism and Disposition September 1987, 15 (5) 718-724;
  5. McClanahan, R H

    1. You have access
      The metabolism of the abortifacient terpene, (R)-(+)-pulegone, to a proximate toxin, menthofuran.
      W P Gordon, A C Huitric, C L Seth, R H McClanahan and S D Nelson
      Drug Metabolism and Disposition September 1987, 15 (5) 589-594;
  6. McKay, S

    1. You have access
      The metabolism of 7-ethylbenz[a]anthracene by rat liver microsomal preparations.
      S McKay, P B Farmer, P D Cary and P L Grover
      Drug Metabolism and Disposition September 1987, 15 (5) 682-694;
  7. Metzler, M

    1. You have access
      Bioactivation of tetrachloroethylene. Role of glutathione S-transferase-catalyzed conjugation versus cytochrome P-450-dependent phospholipid alkylation.
      W Dekant, G Martens, S Vamvakas, M Metzler and D Henschler
      Drug Metabolism and Disposition September 1987, 15 (5) 702-709;
  8. Mico, B A

    1. You have access
      Pharmacokinetics of acetaminophen, vancomycin, and antipyrine in the Hanford miniature swine.
      M B Bailie, D A Federowicz, K Dolce, C Kahn, B A Mico and M S Landi
      Drug Metabolism and Disposition September 1987, 15 (5) 729-730;
  9. Mistry, M

    1. You have access
      Glucuronidation in vitro and in vivo. Comparison of intestinal and hepatic conjugation of morphine, naloxone, and buprenorphine.
      M Mistry and J B Houston
      Drug Metabolism and Disposition September 1987, 15 (5) 710-717;
  10. Mroszczak, E J

    1. You have access
      Ketorolac tromethamine absorption, distribution, metabolism, excretion, and pharmacokinetics in animals and humans.
      E J Mroszczak, F W Lee, D Combs, F H Sarnquist, B L Huang, A T Wu, L G Tokes, M L Maddox and D K Cho
      Drug Metabolism and Disposition September 1987, 15 (5) 618-626;

N

  1. Nadkarni, M

    1. You have access
      The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeys.
      J A Kelley, C L Litterst, J S Roth, D T Vistica, D G Poplack, D A Cooney, M Nadkarni, F M Balis, S Broder and D G Johns
      Drug Metabolism and Disposition September 1987, 15 (5) 595-601;
  2. Nelson, S D

    1. You have access
      The metabolism of the abortifacient terpene, (R)-(+)-pulegone, to a proximate toxin, menthofuran.
      W P Gordon, A C Huitric, C L Seth, R H McClanahan and S D Nelson
      Drug Metabolism and Disposition September 1987, 15 (5) 589-594;

O

  1. Olson, J R

    1. You have access
      Relationship between the murine Ah phenotype and the hepatic uptake and metabolism of 2,3,7,8-tetrachlorodibenzo-p-dioxin.
      E S Shen and J R Olson
      Drug Metabolism and Disposition September 1987, 15 (5) 653-660;

P

  1. Paulson, G D

    1. You have access
      The disposition of N-(4,6-dimethyl-2-pyrimidinyl)benzene[U-14C]sulfonamide in the rat.
      G D Paulson and V J Feil
      Drug Metabolism and Disposition September 1987, 15 (5) 671-675;
  2. Poplack, D G

    1. You have access
      The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeys.
      J A Kelley, C L Litterst, J S Roth, D T Vistica, D G Poplack, D A Cooney, M Nadkarni, F M Balis, S Broder and D G Johns
      Drug Metabolism and Disposition September 1987, 15 (5) 595-601;
  3. Pris, J

    1. You have access
      Direct detection of new flucytosine metabolites in human biofluids by 19F nuclear magnetic resonance.
      J P Vialaneix, M C Malet-Martino, J S Hoffmann, J Pris and R Martino
      Drug Metabolism and Disposition September 1987, 15 (5) 718-724;
  4. Pritchard, J B

    1. You have access
      In vivo and in vitro renal metabolism and excretion of benzoic acid by a marine teleost, the southern flounder.
      M O James and J B Pritchard
      Drug Metabolism and Disposition September 1987, 15 (5) 665-670;

R

  1. Roth, J S

    1. You have access
      The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeys.
      J A Kelley, C L Litterst, J S Roth, D T Vistica, D G Poplack, D A Cooney, M Nadkarni, F M Balis, S Broder and D G Johns
      Drug Metabolism and Disposition September 1987, 15 (5) 595-601;
  2. Russel, F G

    1. You have access
      Physiologically based pharmacokinetic model for the renal clearance of salicyluric acid and the interaction with phenolsulfonphthalein in the dog.
      F G Russel, A C Wouterse and C A van Ginneken
      Drug Metabolism and Disposition September 1987, 15 (5) 695-701;

S

  1. Sarnquist, F H

    1. You have access
      Ketorolac tromethamine absorption, distribution, metabolism, excretion, and pharmacokinetics in animals and humans.
      E J Mroszczak, F W Lee, D Combs, F H Sarnquist, B L Huang, A T Wu, L G Tokes, M L Maddox and D K Cho
      Drug Metabolism and Disposition September 1987, 15 (5) 618-626;
  2. Schwark, W S

    1. You have access
      The development of hepatic drug-metabolizing enzyme activity in the neonatal calf and its effect on drug disposition.
      S E Shoaf, W S Schwark, C L Guard and J G Babish
      Drug Metabolism and Disposition September 1987, 15 (5) 676-681;
  3. Segall, H J

    1. You have access
      Distribution of trans-4-hydroxy-2-hexenal and tandem mass spectrometric detection of its urinary mercapturic acid in the rat.
      C K Winter, H J Segall and A D Jones
      Drug Metabolism and Disposition September 1987, 15 (5) 608-612;
  4. Seth, C L

    1. You have access
      The metabolism of the abortifacient terpene, (R)-(+)-pulegone, to a proximate toxin, menthofuran.
      W P Gordon, A C Huitric, C L Seth, R H McClanahan and S D Nelson
      Drug Metabolism and Disposition September 1987, 15 (5) 589-594;
  5. Shen, E S

    1. You have access
      Relationship between the murine Ah phenotype and the hepatic uptake and metabolism of 2,3,7,8-tetrachlorodibenzo-p-dioxin.
      E S Shen and J R Olson
      Drug Metabolism and Disposition September 1987, 15 (5) 653-660;
  6. Shoaf, S E

    1. You have access
      The development of hepatic drug-metabolizing enzyme activity in the neonatal calf and its effect on drug disposition.
      S E Shoaf, W S Schwark, C L Guard and J G Babish
      Drug Metabolism and Disposition September 1987, 15 (5) 676-681;
  7. Somani, S M

    1. You have access
      Pharmacokinetics and pharmacodynamics of physostigmine in the rat after intravenous administration.
      S M Somani and A Khalique
      Drug Metabolism and Disposition September 1987, 15 (5) 627-633;
  8. Spearman, M E

    1. You have access
      Disposition of the monoclonal antibody-vinca alkaloid conjugate, KS1/4-DAVLB (LY256787), in Fischer 344 rats and rhesus monkeys.
      M E Spearman, R M Goodwin and D Kau
      Drug Metabolism and Disposition September 1987, 15 (5) 640-647;
  9. Sultatos, L G

    1. You have access
      The role of the liver in mediating the acute toxicity of the pesticide methyl parathion in the mouse.
      L G Sultatos
      Drug Metabolism and Disposition September 1987, 15 (5) 613-617;

T

  1. Testa, B

    1. You have access
      Criteria for the acceptability of experimental evidence for the enantiomeric composition of xenobiotics and their metabolites.
      J Caldwell and B Testa
      Drug Metabolism and Disposition September 1987, 15 (5) 587-588;
  2. Tokes, L G

    1. You have access
      Ketorolac tromethamine absorption, distribution, metabolism, excretion, and pharmacokinetics in animals and humans.
      E J Mroszczak, F W Lee, D Combs, F H Sarnquist, B L Huang, A T Wu, L G Tokes, M L Maddox and D K Cho
      Drug Metabolism and Disposition September 1987, 15 (5) 618-626;

V

  1. Vamvakas, S

    1. You have access
      Bioactivation of tetrachloroethylene. Role of glutathione S-transferase-catalyzed conjugation versus cytochrome P-450-dependent phospholipid alkylation.
      W Dekant, G Martens, S Vamvakas, M Metzler and D Henschler
      Drug Metabolism and Disposition September 1987, 15 (5) 702-709;
  2. van Ginneken, C A

    1. You have access
      Physiologically based pharmacokinetic model for the renal clearance of salicyluric acid and the interaction with phenolsulfonphthalein in the dog.
      F G Russel, A C Wouterse and C A van Ginneken
      Drug Metabolism and Disposition September 1987, 15 (5) 695-701;
  3. Vialaneix, J P

    1. You have access
      Direct detection of new flucytosine metabolites in human biofluids by 19F nuclear magnetic resonance.
      J P Vialaneix, M C Malet-Martino, J S Hoffmann, J Pris and R Martino
      Drug Metabolism and Disposition September 1987, 15 (5) 718-724;
  4. Vistica, D T

    1. You have access
      The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeys.
      J A Kelley, C L Litterst, J S Roth, D T Vistica, D G Poplack, D A Cooney, M Nadkarni, F M Balis, S Broder and D G Johns
      Drug Metabolism and Disposition September 1987, 15 (5) 595-601;

W

  1. Winter, C K

    1. You have access
      Distribution of trans-4-hydroxy-2-hexenal and tandem mass spectrometric detection of its urinary mercapturic acid in the rat.
      C K Winter, H J Segall and A D Jones
      Drug Metabolism and Disposition September 1987, 15 (5) 608-612;
  2. Wouterse, A C

    1. You have access
      Physiologically based pharmacokinetic model for the renal clearance of salicyluric acid and the interaction with phenolsulfonphthalein in the dog.
      F G Russel, A C Wouterse and C A van Ginneken
      Drug Metabolism and Disposition September 1987, 15 (5) 695-701;
  3. Wu, A T

    1. You have access
      Ketorolac tromethamine absorption, distribution, metabolism, excretion, and pharmacokinetics in animals and humans.
      E J Mroszczak, F W Lee, D Combs, F H Sarnquist, B L Huang, A T Wu, L G Tokes, M L Maddox and D K Cho
      Drug Metabolism and Disposition September 1987, 15 (5) 618-626;

Y

  1. Young, J F

    1. You have access
      Influence of a purified diet and route of administration on the metabolism and disposition of estradiol in B6C3F1 mice.
      F R Fullerton, D L Greenman and J F Young
      Drug Metabolism and Disposition September 1987, 15 (5) 602-607;
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition
Vol. 15, Issue 5
1 Sep 1987
  • Table of Contents
  • Index by author
  • Back Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • Pharmacokinetics and Disposition of Biologics
  • Physiology of the Neonatal Gastrointestinal System
  • Selective Inhibition of Human CYP2E1 by Clomethiazole
  • Tissue Drug Concentrations: Beyond the Free Drug Hypothesis
  • Liver Zonation Index of Transporters and Enzymes in Mice
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2019 by the American Society for Pharmacology and Experimental Therapeutics